Apple Inc AAPL

Alternate Symbol(s): N.AAPL

Technology Computer Systems

Apple Inc. designs, manufactures and markets smartphones, personal computers, tablets, wearables and accessories, and sells a variety of related services. Its product categories include iPhone, Mac, iPad, and Wearables, Home and Accessories. Its software platforms include iOS, iPadOS, macOS, watchOS, and tvOS. Its services include advertising, AppleCare, cloud services, digital content and payment services. It operates various platforms, including the App Store, that allow customers to discover and download applications and digital content, such as books, music, video, games and podcasts. It also offers digital content through subscription-based services, including Apple Arcade, Apple Fitness+, Apple Music, Apple News+ and Apple TV+. Its products include iPhone 15 Pro, iPhone 15, iPhone 14, iPhone 13, MacBook Air, MacBook Pro, iMac, Mac mini, Mac Studio, Mac Pro, and others. It also provides DarwinAI, which specializes in visual quality inspection using its Explainable AI platform.

NDAQ:AAPL - Post by User

Apple Inc

<< Previous

Bullboard Posts

Next >>

Post by Gowtheron Jun 03, 2022 5:25am

110 Views

Post# 34728773

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance

FSD Pharma ready to proceed with Phase 2 clinical trial of FSD-201 as soon as it gets clearance

FSD Pharma Inc CEO Anthony Durkacz told Proactive that the company is ready to proceed with the planned Phase 2 clinical trial of its FSD-201 drug candidate as soon as it gets the go-ahead from the US Food and Drug Administration and Health Canada. That's after submitting Investigational New Drug (IND) applications to the two bodies this week. Armed with cash of about $50 million following the $16.4 million disposal of its former cannabis production facility in Ontario, Durkacz said FSD is also moving full-steam ahead on its two other drug candidates and may look for other opportunities. A special dividend may also be on the cards, he added.